Pro Medicus Statistics
Total Valuation
Pro Medicus has a market cap or net worth of 12.60 billion. The enterprise value is 12.45 billion.
| Market Cap | 12.60B |
| Enterprise Value | 12.45B |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | Sep 3, 2025 |
Share Statistics
| Current Share Class | 104.47M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 48.67% |
| Owned by Institutions (%) | 15.02% |
| Float | 53.04M |
Valuation Ratios
The trailing PE ratio is 166.83 and the forward PE ratio is 112.66.
| PE Ratio | 166.83 |
| Forward PE | 112.66 |
| PS Ratio | 90.25 |
| PB Ratio | 74.80 |
| P/TBV Ratio | 81.38 |
| P/FCF Ratio | 173.34 |
| P/OCF Ratio | 172.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 110.19, with an EV/FCF ratio of 171.30.
| EV / Earnings | 164.87 |
| EV / Sales | 82.15 |
| EV / EBITDA | 110.19 |
| EV / EBIT | 110.88 |
| EV / FCF | 171.30 |
Financial Position
The company has a current ratio of 6.49, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.49 |
| Quick Ratio | 6.38 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 51.82% and return on invested capital (ROIC) is 229.23%.
| Return on Equity (ROE) | 51.82% |
| Return on Assets (ROA) | 33.09% |
| Return on Invested Capital (ROIC) | 229.23% |
| Return on Capital Employed (ROCE) | 53.38% |
| Weighted Average Cost of Capital (WACC) | 7.57% |
| Revenue Per Employee | 1.06M |
| Profits Per Employee | 572,252 |
| Employee Count | 132 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 4.20 |
Taxes
In the past 12 months, Pro Medicus has paid 31.53 million in taxes.
| Income Tax | 31.53M |
| Effective Tax Rate | 29.45% |
Stock Price Statistics
The stock price has decreased by -31.63% in the last 52 weeks. The beta is 0.60, so Pro Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -31.63% |
| 50-Day Moving Average | 145.19 |
| 200-Day Moving Average | 159.60 |
| Relative Strength Index (RSI) | 42.93 |
| Average Volume (20 Days) | 821 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pro Medicus had revenue of 139.63 million and earned 75.54 million in profits. Earnings per share was 0.72.
| Revenue | 139.63M |
| Gross Profit | 139.43M |
| Operating Income | 103.45M |
| Pretax Income | 107.07M |
| Net Income | 75.54M |
| EBITDA | 103.66M |
| EBIT | 103.45M |
| Earnings Per Share (EPS) | 0.72 |
Balance Sheet
The company has 138.11 million in cash and 1.48 million in debt, with a net cash position of 136.63 million.
| Cash & Cash Equivalents | 138.11M |
| Total Debt | 1.48M |
| Net Cash | 136.63M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 168.47M |
| Book Value Per Share | 1.61 |
| Working Capital | 155.35M |
Cash Flow
In the last 12 months, operating cash flow was 72.99 million and capital expenditures -287,812, giving a free cash flow of 72.70 million.
| Operating Cash Flow | 72.99M |
| Capital Expenditures | -287,812 |
| Free Cash Flow | 72.70M |
| FCF Per Share | n/a |
Margins
Gross margin is 99.85%, with operating and profit margins of 74.09% and 54.10%.
| Gross Margin | 99.85% |
| Operating Margin | 74.09% |
| Pretax Margin | 76.68% |
| Profit Margin | 54.10% |
| EBITDA Margin | 74.24% |
| EBIT Margin | 74.09% |
| FCF Margin | 52.07% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 0.30%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 0.30% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 42.63% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.29% |
| Earnings Yield | 0.60% |
| FCF Yield | 0.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pro Medicus has an Altman Z-Score of 170.27 and a Piotroski F-Score of 4.
| Altman Z-Score | 170.27 |
| Piotroski F-Score | 4 |